Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Neoadjuvant Therapy × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Rituximab 19 Cyclophosphamide 19 Prednisone 13 Lenalidomide 11 Doxorubicin 11 Oxaliplatin 9 Gemcitabine 9 fludarabine 8 Specimen Handling 8 Vincristine 7 Magnetic Resonance Spectroscopy 7 polatuzumab vedotin 6 Etoposide 6 glofitamab 5 CT-P10 5 venetoclax 4 obinutuzumab 4 ibrutinib 4 fludarabine phosphate 4 axicabtagene ciloleucel 4 Biopsy 4 deltacortene 3 Prednisolone 3 Leukapheresis 3 Immunotherapy, Adoptive 3 Ifosfamide 3 tisagenlecleucel 2 prednylidene 2 pembrolizumab 2 acalabrutinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡